Innovation Pharmaceuticals Inc (IPIX)

[Phoenix300]

Cellceutix Announces Business Update Call at 10AM Eastern on November 15

Management to provide Clinical, Regulatory and Financial Updates

BEVERLY, MA – November 9, 2016 – Cellceutix Corporation (OTCQB: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies including dermatology, oncology, anti-inflammatory, and antibiotic applications, today announced that it will host a business update call for analysts and investors on Tuesday, November 15, 2016, starting at 10:00 AM Eastern Time, which will include a corporate and financial update by Leo Ehrlich, CEO, as well as feature a scientific and clinical presentation by Dr. Arthur P. Bertolino, President and Chief Medical Officer of the Company. Following the presentation, management will also answer questions submitted in advance by investors, which can be sent to [e-mail] and must be received by 5PM Eastern on November 13, 2016.

The webcast conference call will be available on the investor relations page of the Company’s website at http://cellceutix.com/events. A web-based archive of the conference call will also be available at the above website following the call.